BioSpectrum Asia
Print this page

Mindray re-elects its directors

02 Jan 2013, BioSpectrum Bureau , BioSpectrum

mindray-medical-re-elects-mr-xu-hang-mr-ronald-ede-and-mr-chen-qingtai-as-directors

Singapore: Shareholders of Mindray Medical, a leading developer, manufacturer and marketer of medical devices, have re-elected its directors Mr Xu Hang, Mr Ronald Ede and Mr Chen Qingtai. Each of them will serve a three-year term.

In addition, Mindray shareholders ratified the appointment of PricewaterhouseCoopers as the company's independent registered public accounting firm for the fiscal year ending December 31, 2012.

 

© Copyright © 2013   CyberMedia (I) Ltd All rights reserved.
Reproduction in whole or in part in any form or medium without written permission is prohibited.